HR-slowing agents

Ivabradine      

Select            
Trial Studied trt Control trt patientstagsROB Trial resulthospitalisation for cardiovascular causes hospitalisation for heart failure

heart failure

ivabradine
SHIFT, 2010       ivabradineplaceboLow risk of bias suggesting-15%-26%
BEAUTIFUL, 2008    NCTivabradine 15mgplaceboLow risk of bias negative-1%

stable angina

ivabradine
Borer (CL2-009) 10mg, 2003     ivabradine 10mgplaceboLow risk of bias -
BEAUTIFUL, 2008    NCTivabradine 15mgplaceboLow risk of bias negative-1%
Borer (CL2-009) 20mg, 2003   ivabradine 20mgplaceboLow risk of bias -
SIGNIFY, 2014     ivabradine 20mgplaceboLow risk of bias negative19%
Borer (CL2-009) 5mg, 2003     ivabradine 5mgplaceboLow risk of bias -
BEAUTIFUL (angina subgroup)   ivabradine 15mgplacebo (on top standard treatment)Low risk of bias suggesting-15%
CL3-018 10mg   ivabradine 10mgplacebo on top of amlodipine -
CL3-018 15mg   ivabradine 15mgplacebo on top of amlodipine -
ASSOCIATE (Tardif), 2009    NCTivabradine 15mgplacebo on top of atenololLow risk of bias -
CL3-023 (15mg)   ivabradineamlodipineLow risk of bias -
CL3-023 (20mg)   ivabradineamlodipineLow risk of bias -
Ruzyllo (CL3-023) 15mg, 2007     ivabradine 15mgamlodipineLow risk of bias -
Ruzyllo (CL3-023) 20mg, 2007     ivabradine 20mgamlodipineLow risk of bias -
INITIATIVE (CL3-017, Tardif) 15mg, 2005   ivabradine 15mgatenololLow risk of bias -
INITIATIVE (CL3-017, Tardif) 20mg, 2005   ivabradine 20mgatenololLow risk of bias -